Bonnie H. Anderson is Cofounder and Executive Chairwoman of Veracyte, a global genomic diagnostics company that aims to transform outcomes for patients all over world at every step of their journey in cancer and other diseases. Ms. Anderson’s career spans over 40 years in regulated diagnostics and life science markets. She cofounded Veracyte in 2008 and served as Chief Executive Officer and Chairman of the Board until June 1, 2021, when she assumed the role of Executive Chairwoman. Ms. Anderson led Veracyte’s initial public offering in 2013, spearheaded commercialization of its market-leading products; and was the architect of the company’s vision to become a global enterprise with a growing menu of advanced genomic diagnostics tests and its own distributed instrument platform.
Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. She serves on the boards of Bruker Corporation and the Biotechnology Innovation Organization (BIO), and is President of the Coalition for 21st Century Medicine. She previously served on the board of Castle Biosciences and is a trustee emeritus of the Keck Graduate Institute of Applied Life Sciences. Ms. Anderson graduated from Indiana University of Pennsylvania with a Bachelor of Science degree in Medical Technology and in 2012 was honored with a “Distinguished Alumni” award. She has received numerous awards for her industry leadership, including: the Wallace H. Coulter Award for Healthcare Innovation (2017); “Fiercest Women in Life Sciences” (FiercePharma 2017); “100 Most Creative People in Business” (Fast Company, 2015); “Most Influential Women in Bay Area Business” and “Bay Area’s Most Admired CEOs” (San Francisco Business Times, 2013 and 2014); and “Women of Influence” (Silicon Valley Business Journal, 2013). Under Ms. Anderson’s leadership, Veracyte has been named a “Top Workplace” by the Bay Area News Group, based solely on employee feedback, for seven consecutive years (2014-2020).